by Single cell genome sequencing is a technique that enables reading genomes of individual cells within a population. It is used for various applications across cancer research, prenatal diagnosis, human embryonic development, stem cell research and drug discovery. This technique has huge potential to transform healthcare sector by enabling deeper understanding of complex diseases at cellular level. Single cells from tissues, tumors and whole organisms are isolated and genome of each cell is amplified and sequenced. Advancements in single-cell analysis techniques are enabling improved accessibility and affordability of the technique. Introduction of new tools for sorting, lysing, and genomic analysis of individual cells is helping lower costs and drive higher throughput.
The global single cell genome sequencing market is estimated to be valued at US$ 2.28 Bn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Advancements in single-cell analysis techniques is one of the primary drivers expected to fuel growth of single cell genome sequencing market over the forecast period. Continuous technological innovations are enabling development of tools for efficiently isolating, lysing, and sequencing DNA or RNA from individual cells. For instance, introduction of microfluidic systems that require very small volume of samples have helped in automating sample preparation process and drive higher throughput. Another key driver for market growth is growing adoption of single cell sequencing techniques by pharmaceutical companies for drug discovery applications. Single cell sequencing helps in gaining understanding of cell-to-cell heterogeneity and better target identification process. These capabilities are driving increasing investments by biopharma players in this area.
Segment Analysis
The single cell genome sequencing market is dominated by the clinical segment, which holds around 65% share of the overall market. This is because single cell genome sequencing helps in disease diagnosis and prognosis by analyzing genetic variations at single-cell resolution. Within the clinical segment, cancer is the leading sub-segment as single cell genome sequencing plays a vital role in cancer research by identifying tumor heterogeneity. It can detect mutations from early stage cancer cells and trace how mutations spread from cell to cell.
PEST Analysis
Political: Regulations supporting stem cell and cancer research have increased funding for single cell genome sequencing projects. However, strict privacy laws pose challenges for data sharing.
Economic: High growth is attributed to increasing healthcare spending on precision medicine and genomics research. Lower equipment costs are improving adoption among SMEs.
Social: Increasing consumer awareness about personalized medicine is driving demand for single cell sequencing to understand genetic variations influencing health outcomes. However, ethical concerns around data usage need addressing.
Technological: Advancements in microfluidics, imaging and bioinformatics are enhancing throughput and analysis. Automation and miniaturization are making single cell sequencing more affordable and accessible to new applications.
Key Takeaways
The Global Single Cell Genome Sequencing Market Demand is expected to witness high growth over the forecast period as it allows comprehensive understanding of genetic variations at single cell resolution. The global single cell genome sequencing market is estimated to be valued at US$ 2.28 Bn in 2023 and is expected to exhibit a CAGR of 3.9% over the forecast period 2023 to 2030.
Regional analysis
North America held the largest market share of over 35% in 2023 owing to strong government funding for genomics research and presence of leading sequencing companies in the US. The Asia Pacific region is anticipated to grow at the highest CAGR during the forecast period, driven by a rise in healthcare spending in China and India along with growing biotech hubs focused on precision medicine research.
Key players
Key players operating in the single cell genome sequencing market are Logitech International SA, Microsoft Corporation, Datadesk Technologies, Inc., Fentek Industries Inc., Adesso AG, Shenzhen V4 Electronic Co., Ltd., Fellowes Limited, Kinesis Corporation, Gold Touch Enterprise Inc., and Posturite UK Ltd. Logitech dominates owing to its comprehensive product portfolio catering to a variety of sequencing platforms.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
